Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZBTB38 Activators

Chemicals classified as ZBTB38 activators encompass a diverse array of molecules that can indirectly influence the activity of ZBTB38 by modulating pathways and processes related to gene transcription regulation. Transcriptional regulation, the direct target of ZBTB38's activity, is tightly regulated by numerous factors including the methylation status of DNA, the acetylation status of histones, and the activity of protein complexes involved in gene silencing.

Some chemicals such as 5-Azacytidine can potentially modulate the activity of ZBTB38 by affecting the methylation status of DNA. Others, namely Trichostatin A, Vorinostat, Romidepsin, and Entinostat, indirectly influence ZBTB38 activity by affecting the acetylation status of histones, a key element in the regulation of gene transcription. Lastly, molecules such as JQ1, I-BET762, PFI-1, EPZ-6438, GSK126, UNC1999, and EED226 can indirectly modulate the activity of ZBTB38 by inhibiting proteins that read or write histone modifications, thereby changing the overall dynamics of gene transcription regulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine is a DNA methyltransferase inhibitor that can indirectly influence ZBTB38 by altering the methylation status of DNA, which can affect transcriptional regulation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is a histone deacetylase (HDAC) inhibitor that can indirectly affect ZBTB38 by changing the acetylation status of histones, a key element in the regulation of gene transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Vorinostat is an HDAC inhibitor that can indirectly affect ZBTB38 by changing the acetylation status of histones.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

Romidepsin is an HDAC inhibitor that can indirectly affect ZBTB38 by changing the acetylation status of histones.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Entinostat is an HDAC inhibitor that can indirectly affect ZBTB38 by changing the acetylation status of histones.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 is a BET bromodomain inhibitor that can indirectly modulate ZBTB38 activity by altering the recognition of acetylated histones by BET proteins, thereby influencing transcriptional regulation.

GSK 525762A

1260907-17-2sc-490339
sc-490339A
sc-490339B
sc-490339C
sc-490339D
5 mg
10 mg
50 mg
100 mg
1 g
$300.00
$540.00
$940.00
$1680.00
$5900.00
(0)

I-BET762 is a BET bromodomain inhibitor that can indirectly modulate ZBTB38 activity by altering the recognition of acetylated histones by BET proteins.

PFI-1

1403764-72-6sc-478504
5 mg
$98.00
(0)

PFI-1 is a BET bromodomain inhibitor that can indirectly modulate ZBTB38 activity by altering the recognition of acetylated histones by BET proteins.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

EPZ-6438 is an inhibitor of EZH2, a component of the PRC2 complex that methylates histone H3, and can indirectly influence ZBTB38 by affecting this key element of gene transcription regulation.

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$92.00
$243.00
$306.00
(0)

GSK126 is an EZH2 inhibitor and can indirectly influence ZBTB38 by affecting the methylation status of histone H3.